The United Laboratories International Holdings Limited
ULIHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -3.10 | 0.06 | 0.07 | 0.20 |
| FCF Yield | 8.02% | 8.48% | 19.28% | 14.99% |
| EV / EBITDA | 3.40 | 2.20 | 1.66 | 2.82 |
| Quality | ||||
| ROIC | 14.07% | 18.21% | 12.17% | 10.42% |
| Gross Margin | 44.21% | 46.11% | 43.84% | 43.40% |
| Cash Conversion Ratio | 0.97 | 0.73 | 1.28 | 1.56 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.68% | 12.29% | 8.92% | 4.96% |
| Free Cash Flow Growth | 35.96% | -21.86% | 17.98% | 2.25% |
| Safety | ||||
| Net Debt / EBITDA | -0.81 | -0.69 | -0.90 | -0.75 |
| Interest Coverage | 89.14 | 49.17 | 24.70 | 23.43 |
| Efficiency | ||||
| Inventory Turnover | 3.15 | 3.31 | 2.94 | 2.74 |
| Cash Conversion Cycle | 77.36 | 58.07 | 64.15 | 48.59 |